Urinary Prostaglandins and Renal Function in Obstructive Jaundice

References

• Pitt H A, Cameron J L, Postier R G, Gadaz T R. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141: 66–72
   PubMed Web of Science ®Google Scholar
• Ozawa K, Yamada T, Tanaka J. The mechanism of suppression of renal function in patients and rabbits with jaundice. Surg Gynecol Obstet 1979; 149: 54–60
   PubMedGoogle Scholar
• Allison M EM, Prentice C RM, Kennedy A C. Renal function and other factors in obstructive jaundice. Br J Surg 1979; 66: 392–397
   PubMedGoogle Scholar
• Bomzon L, Kew M C, Rosendorff C. The effect of phenoxybenzamine and saralasin on the altered renal blood flow distribution in baboons with obstructive jaundice. Clin Exp Pharmacol Physiol 1977; 4: 365–373
   PubMedGoogle Scholar
• Bomzon L, Rosendorff C, Scriven D R, Farr J. The effect of noradrenalin, adrenergic blocking agents, and tyramine on the intrarenal distribution of blood flow in the baboon. Cardiovasc Res 1975; 9: 314–322
   PubMedGoogle Scholar
• Wilkinson S P, Moodie H, Stamatakis J D, Kakkar W, Williams R. Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 1976; 2: 1415–1418
   PubMed Web of Science ®Google Scholar
• Allison M E, Prentice C R, Kennedy A C, Blumgart L H. Renal function and other factors in obstructive jaundice. Br J Surg 1979; 66: 392–397
   PubMedGoogle Scholar
• Boyer T D, Zia P, Reynolds T B. Effect of indo-methacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1978; 77: 215–222
   Google Scholar
• Zipser R D, Hoefs J C, Speckart P F, Zia P K, Horton R. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 1979; 48: 895–900
   PubMed Web of Science ®Google Scholar
• Uemura M, Tsujii T, Fukui H, et al. Urinary prostaglandins and renal function in chronic liver diseases. Scand J Gastroenterol 1986; 21: 75–81
   PubMed Web of Science ®Google Scholar
• Fletcher M S, Westwick J, Kakkar W. Endotoxin, prostaglandins and renal fibrin deposition in obstructive jaundice. Br J Surg 1982; 69: 625–629
   PubMedGoogle Scholar
• Zambraski E J, Dunn M J. Importance of renal prostaglandins in control of renal function after chronic ligation of the common bile duct in dogs. J Lab Clin Med 1984; 4: 549–559
   Google Scholar
• Inagawa T, Ohki S, Sawada M, Hirata F. Studies on extraction, separation and estimation of prostaglandins by radioimmunoassay. J Pharm Soc Jpn 1972; 92: 1187–1194
   PubMedGoogle Scholar
• Frölich J C, Wilson T W, Sweetman B J, et al. Urinary prostaglandins. Identification and origin. J Clin Invest 1975; 55: 763–770
   PubMed Web of Science ®Google Scholar
• Patrono C, Ciabattoni G, Patrignani P. Evidence for a renal origin of urinary thomboxane B2 in health and disease. Adv Prostaglandin Thromboxane Leukotriene Res 1983; 11: 493–498
   PubMedGoogle Scholar
• Zusman R M, Keiser H R. Regulation of prosta-glandin E2 synthesis by angiotensin II, potassium, osmolarity, and dexamethasone. Kidney Int 1980; 17: 277–283
   PubMedGoogle Scholar
• McGiff J C, Crowshaw K, Terragno N A, Malik K U, Lonigro A J. Differential effect of noradrenalin and renal nerve stimulation on vascular resistance in the dog kidney and the release of a prostaglandin E-like substance. Clin Sci 1972; 42: 223–233
   PubMed Web of Science ®Google Scholar
• Anderson F L, Tsagaris T J, Jubiz W, Kuida H. Prostaglandin F and E levels during endotoxin-induced pulmonary hypertension in calves. Am J Physiol 1975; 228: 410–414
   PubMedGoogle Scholar
• Melman A, Weinberger M H. Alterations of the renin-angiotensin system in bile duct ligated dogs on vaned sodium diets. Clin Res 1976; 24: 407
   Google Scholar
• Data J L, Gerber J G, Crump W J, Frölich J C, Hol-Lifield J W, Niea A S. The prostaglandin system: a role in canine barorecemor control of renin release. Cir Res 1978; 42: 454–458
   PubMed Web of Science ®Google Scholar
• Gerber J G, Nies A S, Olsen R D. Control of canine renin release: macula densa requires prostaglandin synthesis. J Physiol 1981; 319: 419–429
   PubMed Web of Science ®Google Scholar
• Bichet D G, Van Putten V J, Schrier R W. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982; 307: 1552–1557
   PubMed Web of Science ®Google Scholar
• Bloom D, McCalden T A, Rosendorff C. Effects of jaundiced plasma on vascular sensitivity to noradrenalin. Kidney Int 1975; 8: 149–157
   PubMedGoogle Scholar
• Zipser R D, Radvan G H, Kronborg I J, Duke R, Little T E. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 1983; 84: 697–703
   PubMed Web of Science ®Google Scholar
• Bugge J F, Vikse A, Dahl E, Slordahl S H, Kill F. Comparison of PGE2 6–keto PGF1α and renin release irom dog kidney;. Acta Physiol 'Scand 1986; 127: 197–205
   PubMedGoogle Scholar
• Pace-Asciak C R, Carrera M C, Nicolaou K C. Prostaglandin I2 has more hypotensive properties than prostaglandin E2 in the normal and spontaneously hypertensive rats. Prostaglandins 1978; 15: 999–1003
   PubMedGoogle Scholar
• Bugge J F, Vikse A, Dahl E, Kill F. Renal degradation and distribution between urinary and venous output of prostaglandins E2 and I2. Acta Physiol Scand 1987; 130: 467–474
   PubMedGoogle Scholar
• Baum M, Stirling G A, Dawson J L. Further study into obstructive jaundice and ischemic renal damage. Br Med J 1969; 2: 229–231
   PubMed Web of Science ®Google Scholar
• Aoyagi T, Lowenstein L M. The effect of bile acids and renal ischemia on renal function. J Lab Clin Med 1968; 71: 686–692
   PubMed Web of Science ®Google Scholar
• Bloom D, McCalden T A, Rosendorff C. The effects of hypercholesterolemic plasma on vascular sensitivity to noradrenalin. Br J Pharmacol 1975; 54: 421–427
   PubMedGoogle Scholar